We heard grumblings about this a year or so ago so it isn't surprising. The FDA says it isn't safe and effective on breast cancer sufferers. It doesn't stop the use of Avastin on other cancers though. Most Drs and many women don't see it the same way as the FDA and are vowing to continue using it hoping insurance companies will continue to pay as long as it is listed as a breast cancer drug. Is this just the FDAs way of cutting an $8000 a month drug(on average) or is there really something to it not being safe and effective for one cancer but not others?Answer Question
Answer by annabarred at 7:36 PM on Jun. 29, 2011
Answer by minnesotanice at 8:12 PM on Jun. 29, 2011
Approval was based on a single study by the manufacturer, which suggested the drug prevented the disease from advancing for an average of 5.5 months. But subsequent studies have failed to replicate the results, and have shown the drug carries serious risks like high blood pressure, heart attacks, and bleeding.
Answer by minnesotanice at 8:17 PM on Jun. 29, 2011
Answer by Carpy at 8:45 PM on Jun. 29, 2011
Answer by Sisteract at 9:52 PM on Jun. 29, 2011
Answer by yourspecialkid at 10:26 PM on Jun. 29, 2011
Answer by minnesotanice at 10:51 PM on Jun. 29, 2011
Answer by minnesotanice at 10:52 PM on Jun. 29, 2011
Next question overall
(Religion & Beliefs)
What do you think of saying G-d at a Military funeral?